Developmental screening in children with CHD: Ages and Stages Questionnaires

Maia M. Noeder, Beth A. Logan, Kari L. Struemph, Nancy Condon, Isabel Mueller, Barbara Sands, Ryan R Davies, Erica Sood

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective Standardised developmental screening tools are important for the evaluation and management of developmental disorders in children with CHD; however, psychometric properties and clinical utility of screening tools, such as the Ages & Stages Questionnaires, Third Edition (ASQ-3), have not been examined in the CHD population. We hypothesised that the ASQ-3 would be clinically useful for this population. Study design ASQ-3 developmental classifications for 163 children with CHD at 6, 12, 24, and/or 36 months of age were compared with those obtained from concurrent developmental testing with the Bayley Scales of Infant and Toddler Development, Third Edition. Results When ASQ-3 screening failure was defined as ≥1 SD below the normative mean, specificity (≥81.9%) and negative predictive value (≥81.0%) were high across ASQ-3 areas. Sensitivity was high for gross motor skills (79.6%), increased with age for communication (35.7-100%), and generally decreased with age for problem solving (73.1-50.0%). When ASQ-3 screening failure was defined as ≥2 SD below the normative mean, specificity (≥93.6%) and positive predictive value (≥74.5%) were generally high across ASQ-3 areas, but sensitivity was low (31.1%) to fair (62.8%). The ASQ-3 showed improved accuracy in predicting delays over clinical risk factors alone. Conclusions The ASQ-3 appears to be a clinically useful tool for screening development in children with CHD, although its utility varied on the basis of developmental area and time point. Clinicians are encouraged to refer children scoring ≥1 SD below the normative mean on any ASQ-3 area for formal developmental evaluation.

Original languageEnglish (US)
Pages (from-to)1447-1454
Number of pages8
JournalCardiology in the Young
Volume27
Issue number8
DOIs
StatePublished - Oct 1 2017

Fingerprint

Child Development
Motor Skills
Psychometrics
Population
Communication
Surveys and Questionnaires

Keywords

  • Assessment
  • cardiology
  • neurodevelopment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Cardiology and Cardiovascular Medicine

Cite this

Noeder, M. M., Logan, B. A., Struemph, K. L., Condon, N., Mueller, I., Sands, B., ... Sood, E. (2017). Developmental screening in children with CHD: Ages and Stages Questionnaires. Cardiology in the Young, 27(8), 1447-1454. https://doi.org/10.1017/S1047951117000415

Developmental screening in children with CHD : Ages and Stages Questionnaires. / Noeder, Maia M.; Logan, Beth A.; Struemph, Kari L.; Condon, Nancy; Mueller, Isabel; Sands, Barbara; Davies, Ryan R; Sood, Erica.

In: Cardiology in the Young, Vol. 27, No. 8, 01.10.2017, p. 1447-1454.

Research output: Contribution to journalArticle

Noeder, MM, Logan, BA, Struemph, KL, Condon, N, Mueller, I, Sands, B, Davies, RR & Sood, E 2017, 'Developmental screening in children with CHD: Ages and Stages Questionnaires', Cardiology in the Young, vol. 27, no. 8, pp. 1447-1454. https://doi.org/10.1017/S1047951117000415
Noeder MM, Logan BA, Struemph KL, Condon N, Mueller I, Sands B et al. Developmental screening in children with CHD: Ages and Stages Questionnaires. Cardiology in the Young. 2017 Oct 1;27(8):1447-1454. https://doi.org/10.1017/S1047951117000415
Noeder, Maia M. ; Logan, Beth A. ; Struemph, Kari L. ; Condon, Nancy ; Mueller, Isabel ; Sands, Barbara ; Davies, Ryan R ; Sood, Erica. / Developmental screening in children with CHD : Ages and Stages Questionnaires. In: Cardiology in the Young. 2017 ; Vol. 27, No. 8. pp. 1447-1454.
@article{f224135ce52c4ce58cfaf3aba493156e,
title = "Developmental screening in children with CHD: Ages and Stages Questionnaires",
abstract = "Objective Standardised developmental screening tools are important for the evaluation and management of developmental disorders in children with CHD; however, psychometric properties and clinical utility of screening tools, such as the Ages & Stages Questionnaires, Third Edition (ASQ-3), have not been examined in the CHD population. We hypothesised that the ASQ-3 would be clinically useful for this population. Study design ASQ-3 developmental classifications for 163 children with CHD at 6, 12, 24, and/or 36 months of age were compared with those obtained from concurrent developmental testing with the Bayley Scales of Infant and Toddler Development, Third Edition. Results When ASQ-3 screening failure was defined as ≥1 SD below the normative mean, specificity (≥81.9{\%}) and negative predictive value (≥81.0{\%}) were high across ASQ-3 areas. Sensitivity was high for gross motor skills (79.6{\%}), increased with age for communication (35.7-100{\%}), and generally decreased with age for problem solving (73.1-50.0{\%}). When ASQ-3 screening failure was defined as ≥2 SD below the normative mean, specificity (≥93.6{\%}) and positive predictive value (≥74.5{\%}) were generally high across ASQ-3 areas, but sensitivity was low (31.1{\%}) to fair (62.8{\%}). The ASQ-3 showed improved accuracy in predicting delays over clinical risk factors alone. Conclusions The ASQ-3 appears to be a clinically useful tool for screening development in children with CHD, although its utility varied on the basis of developmental area and time point. Clinicians are encouraged to refer children scoring ≥1 SD below the normative mean on any ASQ-3 area for formal developmental evaluation.",
keywords = "Assessment, cardiology, neurodevelopment",
author = "Noeder, {Maia M.} and Logan, {Beth A.} and Struemph, {Kari L.} and Nancy Condon and Isabel Mueller and Barbara Sands and Davies, {Ryan R} and Erica Sood",
year = "2017",
month = "10",
day = "1",
doi = "10.1017/S1047951117000415",
language = "English (US)",
volume = "27",
pages = "1447--1454",
journal = "Cardiology in the Young",
issn = "1047-9511",
publisher = "Cambridge University Press",
number = "8",

}

TY - JOUR

T1 - Developmental screening in children with CHD

T2 - Ages and Stages Questionnaires

AU - Noeder, Maia M.

AU - Logan, Beth A.

AU - Struemph, Kari L.

AU - Condon, Nancy

AU - Mueller, Isabel

AU - Sands, Barbara

AU - Davies, Ryan R

AU - Sood, Erica

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Objective Standardised developmental screening tools are important for the evaluation and management of developmental disorders in children with CHD; however, psychometric properties and clinical utility of screening tools, such as the Ages & Stages Questionnaires, Third Edition (ASQ-3), have not been examined in the CHD population. We hypothesised that the ASQ-3 would be clinically useful for this population. Study design ASQ-3 developmental classifications for 163 children with CHD at 6, 12, 24, and/or 36 months of age were compared with those obtained from concurrent developmental testing with the Bayley Scales of Infant and Toddler Development, Third Edition. Results When ASQ-3 screening failure was defined as ≥1 SD below the normative mean, specificity (≥81.9%) and negative predictive value (≥81.0%) were high across ASQ-3 areas. Sensitivity was high for gross motor skills (79.6%), increased with age for communication (35.7-100%), and generally decreased with age for problem solving (73.1-50.0%). When ASQ-3 screening failure was defined as ≥2 SD below the normative mean, specificity (≥93.6%) and positive predictive value (≥74.5%) were generally high across ASQ-3 areas, but sensitivity was low (31.1%) to fair (62.8%). The ASQ-3 showed improved accuracy in predicting delays over clinical risk factors alone. Conclusions The ASQ-3 appears to be a clinically useful tool for screening development in children with CHD, although its utility varied on the basis of developmental area and time point. Clinicians are encouraged to refer children scoring ≥1 SD below the normative mean on any ASQ-3 area for formal developmental evaluation.

AB - Objective Standardised developmental screening tools are important for the evaluation and management of developmental disorders in children with CHD; however, psychometric properties and clinical utility of screening tools, such as the Ages & Stages Questionnaires, Third Edition (ASQ-3), have not been examined in the CHD population. We hypothesised that the ASQ-3 would be clinically useful for this population. Study design ASQ-3 developmental classifications for 163 children with CHD at 6, 12, 24, and/or 36 months of age were compared with those obtained from concurrent developmental testing with the Bayley Scales of Infant and Toddler Development, Third Edition. Results When ASQ-3 screening failure was defined as ≥1 SD below the normative mean, specificity (≥81.9%) and negative predictive value (≥81.0%) were high across ASQ-3 areas. Sensitivity was high for gross motor skills (79.6%), increased with age for communication (35.7-100%), and generally decreased with age for problem solving (73.1-50.0%). When ASQ-3 screening failure was defined as ≥2 SD below the normative mean, specificity (≥93.6%) and positive predictive value (≥74.5%) were generally high across ASQ-3 areas, but sensitivity was low (31.1%) to fair (62.8%). The ASQ-3 showed improved accuracy in predicting delays over clinical risk factors alone. Conclusions The ASQ-3 appears to be a clinically useful tool for screening development in children with CHD, although its utility varied on the basis of developmental area and time point. Clinicians are encouraged to refer children scoring ≥1 SD below the normative mean on any ASQ-3 area for formal developmental evaluation.

KW - Assessment

KW - cardiology

KW - neurodevelopment

UR - http://www.scopus.com/inward/record.url?scp=85017119810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017119810&partnerID=8YFLogxK

U2 - 10.1017/S1047951117000415

DO - 10.1017/S1047951117000415

M3 - Article

C2 - 28376931

AN - SCOPUS:85017119810

VL - 27

SP - 1447

EP - 1454

JO - Cardiology in the Young

JF - Cardiology in the Young

SN - 1047-9511

IS - 8

ER -